Technical Analysis for PFE - Pfizer, Inc.

Grade Last Price % Change Price Change
grade A 43.15 -0.87% -0.38
PFE closed down 1.47 percent on Tuesday, November 20, 2018, on approximately normal volume. The stock fell below its 50 day moving average, damaging its intermediate-term outlook by crossing under that important trendline.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Up Down Down
See historical PFE trend table...

Date Alert Name Type % Chg
Nov 20 Fell Below 50 DMA Bearish -0.87%
Nov 20 180 Bearish Setup Bearish Swing Setup -0.87%
Nov 20 Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -0.87%
Nov 20 20 DMA Support Bullish -0.87%
Nov 20 Outside Day Range Expansion -0.87%
Nov 19 Crossed Above 50 DMA Bullish -2.33%
Nov 19 MACD Bullish Centerline Cross Bullish -2.33%
Nov 19 MACD Bullish Signal Line Cross Bullish -2.33%
Nov 19 Up 3 Days in a Row Strength -2.33%
Nov 16 50 DMA Resistance Bearish -0.83%

Older signals for PFE ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Pfizer Inc., a biopharmaceutical company, discovers, develops, manufactures, and sells medicines for people and animals worldwide. Its Primary Care segment offers human prescription pharmaceutical products primarily prescribed by primary-care physicians for Alzheimer's disease, cardiovascular, erectile dysfunction, genitourinary, major depressive disorder, pain, respiratory, and smoking cessation therapeutic and disease areas. The company's Specialty Care and Oncology segment provides human prescription pharmaceutical products for anti-infectives, endocrine disorders, hemophilia, inflammation, ophthalmology, pulmonary arterial hypertension, specialty neuroscience, and vaccines, as well as oncology and oncology-related illnesses. Its Established Products and Emerging Markets segment offers human prescription pharmaceutical products that have lost patent protection or marketing exclusivity in certain countries and/or regions, as well as that are sold in emerging markets, including Asia, Latin America, the Middle East, Eastern Europe, Africa, Turkey, and Central Europe. The company's Animal Health segment offers products and services to prevent and treat disease in livestock and companion animals, including anti-infectives, vaccines, parasiticides, medicinal feed additives, other pharmaceutical products, and other non-pharmaceutical products. Its Consumer Healthcare segment provides non-prescription products in therapeutic categories, such as dietary supplements, pain management, respiratory, and personal care. The company sells its products to wholesalers, distributors, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, veterinarians, livestock producers, and grocery and convenience stores. Pfizer Inc. has a strategic collaboration with CytomX Therapeutics, Inc. to develop and commercialize Multiple Probody drug conjugates in oncology. The company was founded in 1849 and is headquartered in New York, New York.
Is PFE a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 2 bullish, 0 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 45.81
52 Week Low 33.2
Average Volume 22,423,224
200-Day Moving Average 38.8617
50-Day Moving Average 43.7366
20-Day Moving Average 43.415
10-Day Moving Average 43.75
Average True Range 0.9894
ADX 18.29
+DI 18.7417
-DI 19.0465
Chandelier Exit (Long, 3 ATRs ) 41.6418
Chandelier Exit (Short, 3 ATRs ) 44.6282
Upper Bollinger Band 44.4879
Lower Bollinger Band 42.3421
Percent B (%b) 0.55
BandWidth 4.942531
MACD Line 0.0199
MACD Signal Line 0.0127
MACD Histogram 0.0072
Fundamentals Value
Market Cap 258.89 Billion
Num Shares 5.95 Billion
EPS 1.37
Price-to-Earnings (P/E) Ratio 31.77
Price-to-Sales 4.06
Price-to-Book 3.64
PEG Ratio 2.40
Dividend 1.28
Dividend Yield 2.94%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 45.02
Resistance 3 (R3) 45.14 44.76 44.77
Resistance 2 (R2) 44.76 44.39 44.70 44.68
Resistance 1 (R1) 44.15 44.15 43.96 44.03 44.60
Pivot Point 43.77 43.77 43.68 43.71 43.77
Support 1 (S1) 43.16 43.40 42.97 43.04 42.46
Support 2 (S2) 42.78 43.16 42.72 42.38
Support 3 (S3) 42.17 42.78 42.29
Support 4 (S4) 42.05